The landscape of dementia prognosis has evolved radically with the advent of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based exams which will detect Alzheimer's pathology years just before indicators arise. Though these technological improvements characterize extraordinary progress in comprehension neurode